Hyloris Pharmaceuticals Revenue

In the year 2025, Hyloris Pharmaceuticals had annual revenue of 8.83M EUR, down -9.50%. Hyloris Pharmaceuticals had revenue of 5.49M in the half year ending December 31, 2025, with 197.62% growth.

Revenue

8.83M

Revenue Growth

-9.50%

P/S Ratio

16.93

Revenue / Employee

176.66K

Employees

Market Cap

149.52M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.83M	-927.00K	-9.50%
Dec 31, 2024	9.76M	6.00M	159.64%
Dec 31, 2023	3.76M	1.37M	57.48%
Dec 31, 2022	2.39M	-709.00K	-22.90%
Dec 31, 2021	3.10M	2.92M	1,669.14%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Onward Medical	5.41M
European Medical Solutions	52.80M
Celyad Oncology	21.00K
Financière de Tubize	13.26K
BioSenic	-2.39M
argenx SE	3.61B
UCB SA	7.74B
Oxurion NV	2.00K

Revenue Rankings